View by type:
Articles (4214)
A COVID-19 vaccine might be ready within 18 months. But what happens then?
The world is currently on pause, buying time while an effective vaccine against COVID-19 is developed. Already, several vaccines have entered human trials, and discussions have begun about how the most promising candidates might be manufactured…
A day in the life of a vaccinator in Mali
Going the distance to reach every child, no matter where they live.
Gavi’s role in the COVID-19 response in supported countries
The COVID-19 pandemic has placed a heavy burden on global economies, healthcare systems and other core sectors. Gavi is helping countries reallocate their health system strengthening grants to provide fast and flexible funding for vital resources…
Gavi and global health actors collaborate to accelerate COVID-19 technologies for all
Goal of new global collaboration is to make COVID-19 diagnostics, therapeutics and vaccines available to everybody that needs them as quickly as possible.
Lessons in preparing to distribute COVID-19 vaccine
How the 2009 H1N1 influenza pandemic can help us be better prepared for distributing and administering potential COVID-19 vaccines.
COVID-19 threatens weak health systems in indigenous Amazonian communities
Indigenous groups face unique health challenges. How do we mitigate these risks in our COVID response?
Saudi Arabia pledges US$ 150 million to Gavi COVID response
Pledge follows G20 commitment to provide immediate resources to Gavi.
Reed Hastings and Patty Quillin support Gavi with US$ 30 million donation
Cash donation supports the Alliance’s response to COVID-19 and helps protect the world against new outbreaks of other infectious diseases.
Will wearing a mask protect me from COVID-19?
How exactly is the COVID-19 virus spread and will a mask protect me?
Why a gender lens is needed for the COVID-19 response
The immediate and long-term consequences of the coronavirus pandemic are disproportionately impacting the lives of women and girls, and the most marginalised.
Can routine immunisation be carried out safely during COVID-19 pandemic?
How does the benefit of stopping the spread of coronavirus weigh up against the risks from diseases such as measles?
